Enhancing Disease Surveillance and Pharmacovigilance Practices for RTS,S/AS01E Malaria Vaccine Rollout in Ghana, Kenya, and Malawi: Strategies, Impact, Challenges, and Lessons Learned - Summary - MDSpire
Advertisement
Enhancing Disease Surveillance and Pharmacovigilance Practices for RTS,S/AS01E Malaria Vaccine Rollout in Ghana, Kenya, and Malawi: Strategies, Impact, Challenges, and Lessons Learned
To enhance disease monitoring and pharmacovigilance during the rollout of the RTS,S/AS01E malaria vaccine in Ghana, Kenya, and Malawi, focusing on healthcare professionals' training and tool development.
Approach:
Training and Tools: Tailored trainings and practical tools, including both paper-based and digital formats, were developed for healthcare professionals to improve knowledge and reporting of adverse events.
Capacity Building: The initiative aimed to strengthen pharmacovigilance systems through active safety surveillance and predefined adverse events of interest.
Key Findings:
Trainings were well received but faced challenges such as resource limitations and over-familiarity with materials.
Limited uptake of newly introduced digital tools was noted.
Interpretation:
The strategies and challenges encountered during the RTS,S/AS01E rollout may inform future pharmacovigilance initiatives in similar contexts.
Limitations:
Resource limitations affected training effectiveness.
Over-familiarity with training materials may have reduced engagement.
Conclusion:
Insights gained from this initiative could support future capacity-building efforts in low- and middle-income countries for safer vaccine implementation.